1.Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression

Zhang, JM, Liu, P, C     More...

Zhang, JM, Liu, P, Chen, JW, Yao, DH, Liu, Q, Zhang, JH, Zhang, HW, Leung, ELH, Yao, XJ, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 187,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2022影響因子:  9.3 

2.CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer

Wang, J, Li, RZ, Wan     More...

Wang, J, Li, RZ, Wang, WJ, Pan, HD, Xie, C, Yau, LF, Wang, XX, Long, WL, Chen, RH, Liang, TL, Ma, LR, Li, JX, Huang, JM, Wu, QB, Liu, L, He, JX, Leung, ELH     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 194,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2022影響因子:  9.3 

3.Traditional Patchouli essential oil modulates the host's immune responses and gut microbiota and exhibits potent anti-cancer effects in Apc(Min /+) mice

Leong, W, Huang, GX,     More...

Leong, W, Huang, GX, Liao, WL, Xia, WR, Li, XA, Su, ZR, Liu, L, Wu, Q, Wong, VKW, Law, BYK, Xia, CL, Guo, XL, Khan, I, Hsiao, WLW     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 176,

收錄情况： WOS SCOPUS

WOS核心合集引用: 17  2022影響因子:  9.3  发表年影響因子:  9.3 

4.Elucidation of the anti-inflammatory mechanism of Er Miao San by integrative approach of network pharmacology and experimental verification

Guo, Bin, Zhao, CaiP     More...

Guo, Bin, Zhao, CaiPing, Zhang, Chuanhai, Xiao, Yao, Yan, Guangli, Liu, Liang, Pan, Hudan     Less

Pharmacological Research[1043-6618], Published 2022, Volume 175,

收錄情况： WOS SCOPUS

WOS核心合集引用: 40  2022影響因子:  9.3  发表年影響因子:  9.3 

5.IKK beta increases neuropilin-2 and promotes the inhibitory function of CD9(+) Bregs to control allergic diseases

Wang, YY, Deng, WD,     More...

Wang, YY, Deng, WD, Liu, J, Yang, Q, Chen, ZY, Su, JB, Xu, JL, Liang, QH, Li, T, Liu, L, Li, XJ     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 185,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  9.3  发表年影響因子:  9.3 

6.Macrophage 3D migration: A potential therapeutic target for inflammation and deleterious progression in diseases

GAO, WanJiao, LIU, M     More...

GAO, WanJiao, LIU, MengNan, YAO, YunDa, LIU, Liang, ZHOU, Hua, LIU, JianXin, LIU, ZhongQiu, HE, HuanHuan     Less

Pharmacological Research[1043-6618], Published 2021, Volume 167,

收錄情况： WOS SCOPUS

WOS核心合集引用: 18  2022影響因子:  9.3  发表年影響因子:  10.334 

7.Suppression of macrophage migration by down-regulating Src/FAK/P130Cas activation contributed to the anti-inflammatory activity of sinomenine

Gao, WanJiao, Xie, Y     More...

Gao, WanJiao, Xie, Yie, Luo, Pei, Liu, Liang, Zhou, Hua, Liu, JianXin, Liu, ZhongQiu     Less

Pharmacological Research[1043-6618], Published 2021, Volume 167,

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2022影響因子:  9.3  发表年影響因子:  10.334 

8.Icariin enhances youth-like features by attenuating the declined gut microbiota in the aged mice

Li, Xiaoang, Khan, I     More...

Li, Xiaoang, Khan, Imran, Xia, Wenrui, Huang, Guoxin, Liu, Liang, Law, Betty Yuen Kwan, Yin, Lin, Liao, Weilin, Leong, Waikit, Han, Ruixuan, Wong, Vincent Kam Wai, Hsiao, W.L. Wendy, Xia, Chenglai, Guo, Xiaoling     Less

Pharmacological Research[1043-6618], Published 2021, Volume 168,

收錄情况： WOS SCOPUS

WOS核心合集引用: 22  2022影響因子:  9.3  发表年影響因子:  10.334 

9.Saponins isolated from Radix polygalae extent lifespan by modulating complement C3 and gut microbiota

Zeng, W, Wu, AG, Zho     More...

Zeng, W, Wu, AG, Zhou, XG, Khan, I, Zhang, RL, Lo, HH, Qu, LQ, Song, LL, Yun, XY, Wang, HM, Chen, J, Ng, JPL, Ren, F, Yuan, SY, Yu, L, Tang, Y, Huang, GX, Wong, VKW, Chung, SK, Mok, SWF, Qin, DL, Sun, HL, Liu, L, Hsiao, WLW, Law, BYK     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 170,

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2022影響因子:  9.3  发表年影響因子:  10.334 

10.Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis

Dias, IRDR, Lo, HH,     More...

Dias, IRDR, Lo, HH, Zhang, KX, Law, BYK, Nasim, AA, Chung, SK, Wong, VKW, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 170,

收錄情况： WOS SCOPUS

WOS核心合集引用: 22  2022影響因子:  9.3  发表年影響因子:  10.334 

11.Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Li, JX, Li, RZ, Sun,     More...

Li, JX, Li, RZ, Sun, A, Zhou, H, Neher, E, Yang, JS, Huang, JM, Zhang, YZ, Jiang, ZB, Liang, TL, Ma, LR, Wang, J, Wang, XR, Fan, XQ, Huang, J, Xie, Y, Liu, L, Tang, L, Leung, ELH, Yan, PY     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 171,

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2022影響因子:  9.3  发表年影響因子:  10.334 

12.Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry

Zhang, DQ, Hamdoun,     More...

Zhang, DQ, Hamdoun, S, Chen, RH, Yang, LJ, Ip, CK, Qu, YQ, Li, RF, Jiang, HM, Yang, ZF, Chung, SK, Liu, L, Wong, VKW     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 172,

收錄情况： WOS SCOPUS

WOS核心合集引用: 37  2022影響因子:  9.3  发表年影響因子:  10.334 

13.SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells

Xu, SuWei, Law, Bett     More...

Xu, SuWei, Law, Betty Yuen Kwan, Qu, Steven Li Qun, Hamdoun, Sami, Zhang, Wei, Guo, JianRu, Mok, Simon Wing Fai, Zhang, David Wei, Liu, Liang, Wong, Vincent Kam Wai, Efferth, Thomas, Chen, Juan, Wu, AnGuo, Xia, Chenglai, Sugimoto, Yoshikazu     Less

Pharmacological Research[1043-6618], Published 2020, Volume 153,

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2022影響因子:  9.3  发表年影響因子:  7.658 

14.Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020

Zheng, Y, Xiong, C,     More...

Zheng, Y, Xiong, C, Liu, YQ, Qian, X, Tang, YJ, Liu, L, Leung, ELH, Wang, MF     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2020, Volume 157,

收錄情况： WOS SCOPUS

WOS核心合集引用: 48  2022影響因子:  9.3  发表年影響因子:  7.658 

15.ISO/TC 249 platform promotes the development of international standardization and trade for the Chinese medicines industry

Huang, YuFeng, He, F     More...

Huang, YuFeng, He, Fan, Xie, Ying, Liu, Liang, Zhou, Hua     Less

Pharmacological Research[1043-6618], Published 2020, Volume 160,

收錄情况： WOS SCOPUS

WOS核心合集引用: 11  2022影響因子:  9.3  发表年影響因子:  7.658 

16.Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients

Pan, HuDan, Yao, Xia     More...

Pan, HuDan, Yao, XiaoJun, Wang, WanYing, Liu, Liang, Lau, HungYan     Less

Pharmacological Research[1043-6618], Published 2020, Volume 159,

收錄情况： WOS SCOPUS

WOS核心合集引用: 14  2022影響因子:  9.3  发表年影響因子:  7.658 

17.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway

Xie, YaJia, Gao, Wei     More...

Xie, YaJia, Gao, WeiNa, Wu, QiBiao, Yao, XiaoJun, Jiang, ZeBo, Wang, YuWei, Wang, WenJun, Hussain, Shahid, Liu, Liang, Leung, Elaine LaiHan, Fan, XingXing, Li, Wei     Less

Pharmacological Research[1043-6618], Published 2020, Volume 159,

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2022影響因子:  9.3  发表年影響因子:  7.658 

18.The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis

He, YuFei, Mai, ChuT     More...

He, YuFei, Mai, ChuTian, Pan, Hudan, Liu, Liang, Xie, Ying, Huang, Yadan, Luo, HaiBin     Less

Pharmacological Research[1043-6618], Published 2020, Volume 161,

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2022影響因子:  9.3  发表年影響因子:  7.658 

19.Current Policies and Measures on the Development of Traditional Chinese Medicine in China

Wang, WanYing, Zhou,     More...

Wang, WanYing, Zhou, Hua, Liu, Liang, Wang, YaFeng, Sang, BinSheng     Less

Pharmacological Research[1043-6618], Published 2020, Volume 163,

收錄情况： WOS SCOPUS

WOS核心合集引用: 57  2022影響因子:  9.3  发表年影響因子:  7.658 

20.Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling

Zhang, Yueyang, Zou,     More...

Zhang, Yueyang, Zou, Binhua, Tan, Yanhui, Su, Jianbing, Wang, Yiyuan, Xu, Jialan, Tao, Lei, Li, Xiaojuan, Zhou, Hua, Liu, Liang     Less

Pharmacological Research[1043-6618], Published 2019, Volume 142, Pages 140-150

收錄情况： WOS SCOPUS

WOS核心合集引用: 25  2022影響因子:  9.3  发表年影響因子:  5.893